Are you a journalist?

Get to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

  • Post date
    03/15/2017
    Annual General Meeting in ALK-Abelló A/S held on 15 March 2017
  • Post date
    03/03/2017
    ALK appoints SVP of R&D for North America and International Markets
  • Post date
    02/27/2017
    ALK’s ACARIZAX® data results in significant change to the GINA asthma management strategy: Sublingual allergy immunotherapy (SLIT) recommended as a treatment option in patients with house dust mite allergic asthma
  • Post date
    02/14/2017
    Annual General Meeting in ALK-Abelló A/S on 15 March 2017
  • Post date
    01/10/2017
    Carsten Hellmann joins ALK as new President and CEO
  • Post date
    01/04/2017
    ALK upgrades its full-year 2016 financial outlook following better than expected Q4 sales
  • Post date
    12/22/2016
    ALK strengthens its US presence through acquisition
  • Post date
    12/14/2016
    ALK – Financial calendar for the 2017 financial year
  • Post date
    12/02/2016
    Notification of ownership in ALK

Media Relations

Per Plotnikof
Vice President,
Corporate Communications,
Investor Relations and Strategic Planning
Phone: +45 22612525
Email: PPIDK@alk.net

Jeppe Ilkjær
Media Relations Manager
Corporate Communications
Phone: +45 30502014
Email: Jeppe.Ilkjaer@alk.net

Journalists are always welcome to contact ALK’s Media Relations team.
Flemming Pedersen, CFO
Helle Skov, EVP Product Supply
Søren Niegel, EVP Commercial Operations
Henrik Jacobi, EVP Research and Development
Production facilities, Hørsholm
Production facilities, Hørsholm
Production facilities, Hørsholm
ALK HQ, Hørsholm
Last updated: 2017.01.11